SARAH HARTMANN: Open Payments
NPI 1881108413 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,665 in 81 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,665
Food & beverage: $1,665
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $470 |
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $337 |
| Madrigal Pharmaceuticals | 13 | $250 |
| Regeneron Healthcare Solutions, Inc. | 3 | $99 |
| Aimmune Therapeutics, Inc. | 5 | $97 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $94 |
| GENZYME CORPORATION | 2 | $87 |
| Ardelyx, Inc. | 4 | $60 |
| Intercept Pharmaceuticals, Inc. | 2 | $37 |
| QOL Medical, LLC | 2 | $36 |
Products named: ENTYVIO, REZDIFFRA, RINVOQ, DUPIXENT, ZENPEP, XIFAXAN, IBSRELA, SKYRIZI.
Industry payments across MO — which companies pay providers there.
